Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.

Desbois M, Le Vu P, Coutzac C, Marcheteau E, Béal C, Terme M, Gey A, Morisseau S, Teppaz G, Boselli L, Jacques Y, Béchard D, Tartour E, Cassard L, Chaput N.

J Immunol. 2016 Jul 1;197(1):168-78. doi: 10.4049/jimmunol.1600019. Epub 2016 May 23.

2.

Effects of Novel Supramaximal Interval Training Versus Continuous Training on Performance in Preconditioned Collegiate, National, and International Class Rowers.

Richer SD, Nolte VW, Bechard DJ, Belfry GR.

J Strength Cond Res. 2016 Jun;30(6):1752-62. doi: 10.1519/JSC.0000000000001274.

PMID:
27213500
3.

Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.

Vincent M, Teppaz G, Lajoie L, Solé V, Bessard A, Maillasson M, Loisel S, Béchard D, Clémenceau B, Thibault G, Garrigue-Antar L, Jacques Y, Quéméner A.

MAbs. 2014 Jul-Aug;6(4):1026-37.

4.

The effect of walking poles on the knee adduction moment in patients with varus gonarthrosis.

Bechard DJ, Birmingham TB, Zecevic AA, Jones IC, Leitch KM, Giffin JR, Jenkyn TR.

Osteoarthritis Cartilage. 2012 Dec;20(12):1500-6. doi: 10.1016/j.joca.2012.08.014. Epub 2012 Aug 31.

5.

Septic pulmonary embolism in a patient with defibrillator lead endocarditis.

Ali A, Raza S, Khan R, Bechard D, Kaszala K, Jovin IS.

Am J Respir Crit Care Med. 2012 Jan 15;185(2):e2. doi: 10.1164/rccm.201105-0777IM. No abstract available.

PMID:
22246711
6.

Toe-out, lateral trunk lean, and pelvic obliquity during prolonged walking in patients with medial compartment knee osteoarthritis and healthy controls.

Bechard DJ, Birmingham TB, Zecevic AA, Jones IC, Giffin JR, Jenkyn TR.

Arthritis Care Res (Hoboken). 2012 Apr;64(4):525-32. doi: 10.1002/acr.21584.

7.

Time-varying behaviour, test-retest reliability and concurrent validity of lateral trunk lean and toe-out angles during prolonged treadmill walking.

Bechard DJ, Birmingham TB, Zecevic AA, Jenkyn TR.

Gait Posture. 2011 May;34(1):81-5. doi: 10.1016/j.gaitpost.2011.03.017. Epub 2011 Apr 8.

PMID:
21482116
8.

[Evaluation of thromboprophylaxis in patients hospitalized in a tertiary care center: an applicable model of clinical practice evaluation. Revision of 320 cases].

Lanthier L, Béchard D, Viens D, Touchette M.

J Mal Vasc. 2011 Feb;36(1):3-8. doi: 10.1016/j.jmv.2010.10.005. Epub 2010 Dec 9. French.

PMID:
21145677
9.

Total kinetic energy production of body segments is different between racing and training paces in elite Olympic rowers.

Bechard DJ, Nolte V, Kedgley AE, Jenkyn TR.

Sports Biomech. 2009 Sep;8(3):199-211. doi: 10.1080/14763140903229518.

PMID:
19891198
10.

Chronic antiplatelet therapy and mortality among patients with infective endocarditis.

Pepin J, Tremblay V, Bechard D, Rodier F, Walker C, Dufresne D, Lafontaine A, Li N, Lacroix C, Lanthier L.

Clin Microbiol Infect. 2009 Feb;15(2):193-9. doi: 10.1111/j.1469-0691.2008.02665.x. Epub 2009 Jan 22.

11.

Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.

Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, Lortat-Jacob H, Bechard D, Lassalle P, Delehedde M.

Biochim Biophys Acta. 2006 Jan;1765(1):25-37. Epub 2005 Aug 26. Review.

PMID:
16168566
12.

Overexpression of endocan induces tumor formation.

Scherpereel A, Gentina T, Grigoriu B, Sénéchal S, Janin A, Tsicopoulos A, Plénat F, Béchard D, Tonnel AB, Lassalle P.

Cancer Res. 2003 Sep 15;63(18):6084-9.

13.

Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity.

Béchard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, Aumercier M, Vazeux R, Richet C, Degand P, Jude B, Janin A, Fernig DG, Tonnel AB, Lassalle P.

J Biol Chem. 2001 Dec 21;276(51):48341-9. Epub 2001 Oct 5.

14.

Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1.

Béchard D, Scherpereel A, Hammad H, Gentina T, Tsicopoulos A, Aumercier M, Pestel J, Dessaint JP, Tonnel AB, Lassalle P.

J Immunol. 2001 Sep 15;167(6):3099-106.

15.

Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies.

Bechard D, Meignin V, Scherpereel A, Oudin S, Kervoaze G, Bertheau P, Janin A, Tonnel A, Lassalle P.

J Vasc Res. 2000 Sep-Oct;37(5):417-25.

PMID:
11025405
16.

Activation of Xenopus eggs by the kinase inhibitor 6-DMAP suggests a differential regulation of cyclin B and p39(mos) proteolysis.

Bodart JF, Béchard D, Bertout M, Gannon J, Rousseau A, Vilain JP, Flament S.

Exp Cell Res. 1999 Dec 15;253(2):413-21.

PMID:
10585264
17.

Inhibition of protein tyrosine phosphatases blocks calcium-induced activation of metaphase II-arrested oocytes of Xenopus laevis.

Bodart JF, Béchard D, Bertout M, Rousseau A, Gannon J, Vilain JP, Flament S.

FEBS Lett. 1999 Aug 27;457(2):175-8.

18.

Gastroesophageal reflux-induced asthma: new insights.

Bechard DE, Schubert ML.

Gastroenterology. 1998 Apr;114(4):849-50. No abstract available.

PMID:
9547105
19.

Release of endothelin in relation to tumor necrosis factor-alpha in porcine Pseudomonas aeruginosa-induced septic shock.

Han JJ, Windsor A, Drenning DH, Leeper-Woodford S, Mullen PG, Bechard DE, Sugerman HJ, Fowler AA 3rd.

Shock. 1994 May;1(5):343-6.

PMID:
7743336
20.

Measles pneumonia. Treatment of a near-fatal case with corticosteroids and vitamin A.

Rupp ME, Schwartz ML, Bechard DE.

Chest. 1993 May;103(5):1625-6.

PMID:
8486065
21.

A young man with sclerosing cholangitis.

Adlakha A, Shuster L, Bechard DL.

Hosp Pract (Off Ed). 1992 May 15;27(5):45, 49, 52. No abstract available.

PMID:
1577890
22.

Primary thrombocytosis and myocardial ischemic syndrome in a young woman.

Adlakha A, Bechard DL, Geer MR.

Am Heart J. 1992 Mar;123(3):786-90. No abstract available.

PMID:
1539533
23.

Imipramine-induced syndrome of inappropriate antidiuretic hormone secretion.

Adlakha A, Manocha AP, Bechard DL.

South Med J. 1991 Dec;84(12):1507-9. No abstract available.

PMID:
1749990
24.

Anti-CD18 antibody attenuates neutropenia and alveolar capillary-membrane injury during gram-negative sepsis.

Walsh CJ, Carey PD, Cook DJ, Bechard DE, Fowler AA, Sugerman HJ.

Surgery. 1991 Aug;110(2):205-11; discussion 211-2.

PMID:
1677491
25.

In situ pulmonary vascular perfusion for improved recovery of pulmonary intravascular macrophages.

Fowler AA, Carey PD, Walsh CJ, Sessler CN, Mumaw VR, Bechard DE, Leeper-Woodford SK, Fisher BJ, Blocher CR, Byrne TK, et al.

Microvasc Res. 1991 May;41(3):328-44.

PMID:
1649374
26.

CD18 adhesion receptors, tumor necrosis factor, and neutropenia during septic lung injury.

Walsh CJ, Leeper-Woodford SK, Carey PD, Cook DJ, Bechard DE, Fowler AA, Sugerman HJ.

J Surg Res. 1991 Apr;50(4):323-9.

PMID:
1673483
27.

Fatal Cunninghamella bertholletiae infection in an immunocompetent patient.

Zeilender S, Drenning D, Glauser FL, Bechard D.

Chest. 1990 Jun;97(6):1482-3.

PMID:
2347237
28.

In vivo interleukin-2 activated sheep lung lymph lymphocytes increase ovine vascular endothelial permeability by non-lytic mechanisms.

Bechard DE, Fairman RP, Hinshaw DB, Fowler AA, Glauser FL.

Eur J Cancer. 1990;26(10):1074-8.

PMID:
2148883
29.

Nonspecific cytotoxicity of recombinant interleukin-2 activated lymphocytes.

Bechard DE, Gudas SA, Sholley MM, Grant AJ, Merchant RE, Fairman RP, Fowler AA, Glauser FL.

Am J Med Sci. 1989 Jul;298(1):28-33.

PMID:
2665484
30.

Assessment of exercise oxygen consumption: reply.

Wetstein L, Bechard D.

Ann Thorac Surg. 1989 Apr;47(4):639. No abstract available.

PMID:
2712638
31.

Cardiorespiratory and cellular changes with interleukin 2 infusion in sheep.

Glauser FL, Bechard DE, DeBlois GG, Fowler AA, Merchant RE, Jesmok G, Fairman RP.

J Appl Physiol (1985). 1989 Jan;66(1):128-34.

PMID:
2783928
32.

Cardiopulmonary toxicity of adoptive immunotherapy.

Glauser FL, DeBlois G, Bechard D, Fowler AA, Merchant R, Fairman RP.

Am J Med Sci. 1988 Dec;296(6):406-12. Review.

PMID:
3063115
33.
34.

Macrophage spreading disparity: alveolar vs peritoneal.

Bechard DE, Fisher BJ, Kessler FK, Carchman RA, Fowler AA.

J Clin Lab Immunol. 1988 Jun;26(2):67-71.

PMID:
3193446
35.

A comparison of the cardiopulmonary effects of continuous versus bolus infusion of recombinant interleukin-2 in sheep.

Glauser FL, DeBlois GG, Bechard DE, Merchant RE, Grant AJ, Fowler AA, Fairman RP.

Cancer Res. 1988 Apr 15;48(8):2221-5.

36.

Cardiopulmonary effects of recombinant interleukin-2 infusion in sheep.

Glauser FL, DeBlois GG, Bechard DE, Merchant RE, Grant AJ, Fowler AA, Fairman RP.

J Appl Physiol (1985). 1988 Mar;64(3):1030-7.

PMID:
3259225
37.

Responsiveness of guinea pig alveolar cells.

Kessler FK, Fisher BJ, Bechard DE, Fowler AA, Carchman RA.

Lung. 1988;166(1):33-46.

PMID:
2826933
38.

The adult respiratory distress syndrome. Cell populations and soluble mediators in the air spaces of patients at high risk.

Fowler AA, Hyers TM, Fisher BJ, Bechard DE, Centor RM, Webster RO.

Am Rev Respir Dis. 1987 Nov;136(5):1225-31.

PMID:
3674583
39.

Assessment of exercise oxygen consumption as preoperative criterion for lung resection.

Bechard D, Wetstein L.

Ann Thorac Surg. 1987 Oct;44(4):344-9.

PMID:
3662680
40.

Increase of rat pulmonary microvascular permeability to albumin by recombinant interleukin-2.

Fairman RP, Glauser FL, Merchant RE, Bechard D, Fowler AA.

Cancer Res. 1987 Jul 1;47(13):3528-32.

41.

The causes and evaluation of chronic hypercapnea.

Glauser FL, Fairman RP, Bechard D.

Chest. 1987 May;91(5):755-9. Review. No abstract available.

PMID:
3552467
42.

Fatal pulmonary fibrosis from low-dose bleomycin therapy.

Bechard DE, Fairman RP, DeBlois GG, Via CT.

South Med J. 1987 May;80(5):646-9.

PMID:
2437659
43.

Penetration of aztreonam into human bronchial secretions.

Bechard DL, Hawkins SS, Dhruv R, Friedhoff LT.

Antimicrob Agents Chemother. 1985 Feb;27(2):263-4.

44.

Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.

Bechard DL, Hawkins SH, Sutherland SC.

Am J Med. 1984 Dec 21;77(6A):13-6.

PMID:
6097117
45.

The efficacy of ceftizoxime in the therapy of bacteraemia.

Bechard DL.

J Antimicrob Chemother. 1982 Nov;10 Suppl C:175-81. No abstract available.

PMID:
6296003
46.

Neuritic growth maintained near the lesion site long after spinal cord transection in the newborn rat.

Bernstein DR, Bechard DE, Stelzner DJ.

Neurosci Lett. 1981 Oct;26(1):55-60.

PMID:
7290538
47.

Endocarditis caused by Moraxella nonliquefaciens.

Bechard DL, LeFrock JL, Tillotson JR.

South Med J. 1979 Nov;72(11):1485-7.

PMID:
505092
48.

Utilization of Selenocysteine by a Cysteinyl-tRNA Synthetase from Phaseolus aureus.

Shrift A, Bechard D, Harcup C.

Plant Physiol. 1976 Sep;58(3):248-52.

Supplemental Content

Loading ...
Support Center